BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schebb NH, Kühn H, Kahnt AS, Rund KM, O'Donnell VB, Flamand N, Peters-Golden M, Jakobsson PJ, Weylandt KH, Rohwer N, Murphy RC, Geisslinger G, FitzGerald GA, Hanson J, Dahlgren C, Alnouri MW, Offermanns S, Steinhilber D. Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far? Front Pharmacol 2022;13:838782. [PMID: 35308198 DOI: 10.3389/fphar.2022.838782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Kahnt AS, Schebb NH, Steinhilber D. Formation of lipoxins and resolvins in human leukocytes. Prostaglandins Other Lipid Mediat 2023;166:106726. [PMID: 36878381 DOI: 10.1016/j.prostaglandins.2023.106726] [Reference Citation Analysis]
2 Aukema HM, Ravandi A. Factors affecting variability in free oxylipins in mammalian tissues. Curr Opin Clin Nutr Metab Care 2023;26:91-8. [PMID: 36892958 DOI: 10.1097/MCO.0000000000000892] [Reference Citation Analysis]
3 Fiore NT, Debs SR, Hayes JP, Duffy SS, Moalem-Taylor G. Pain-resolving immune mechanisms in neuropathic pain. Nat Rev Neurol 2023. [PMID: 36859719 DOI: 10.1038/s41582-023-00777-3] [Reference Citation Analysis]
4 Yasmeen N, Selvaraj H, Lakhawat SS, Datta M, Sharma PK, Jain A, Khanna R, Srinivasan J, Kumar V. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Biochem Pharmacol 2023;209:115437. [PMID: 36731803 DOI: 10.1016/j.bcp.2023.115437] [Reference Citation Analysis]
5 Millar B, de Gaetano M. Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies. Front Pharmacol 2023;14:1125858. [PMID: 36865918 DOI: 10.3389/fphar.2023.1125858] [Reference Citation Analysis]
6 Serezani CH, Divangahi M, Peters-Golden M. Leukotrienes in Innate Immunity: Still Underappreciated after All These Years? J Immunol 2023;210:221-7. [PMID: 36649580 DOI: 10.4049/jimmunol.2200599] [Reference Citation Analysis]
7 Weylandt KH, Karber M, Xiao Y, Zhang IW, Pevny S, Blüthner E, von Schacky C, Rothe M, Schunck WH, Pape UF. Impact of intravenous fish oil on omega-3 fatty acids and their derived lipid metabolites in patients with parenteral nutrition. JPEN J Parenter Enteral Nutr 2023;47:287-300. [PMID: 36164258 DOI: 10.1002/jpen.2448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 de Marco Castro E, Kampschulte N, Murphy CH, Schebb NH, Roche HM. Oxylipin status, before and after LC n-3 PUFA supplementation, has little relationship with skeletal muscle biology in older adults at risk of sarcopenia. Prostaglandins Leukot Essent Fatty Acids 2023;189:102531. [PMID: 36645979 DOI: 10.1016/j.plefa.2022.102531] [Reference Citation Analysis]
9 Lubrano V, Ndreu R, Balzan S. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis. Int J Mol Sci 2023;24. [PMID: 36675152 DOI: 10.3390/ijms24021637] [Reference Citation Analysis]
10 Thompson M, Ulu A, Mukherjee M, Yuil-Valdes AG, Thoene M, Van Ormer M, Slotkowski R, Mauch T, Anderson-Berry A, Hanson CK, Nordgren TM, Natarajan SK. Something Smells Fishy: How Lipid Mediators Impact the Maternal-Fetal Interface and Neonatal Development. Biomedicines 2023;11. [PMID: 36672679 DOI: 10.3390/biomedicines11010171] [Reference Citation Analysis]
11 Hartung NM, Mainka M, Pfaff R, Kuhn M, Biernacki S, Zinnert L, Schebb NH. Development of a quantitative proteomics approach for cyclooxygenases and lipoxygenases in parallel to quantitative oxylipin analysis allowing the comprehensive investigation of the arachidonic acid cascade. Anal Bioanal Chem 2023;415:913-33. [PMID: 36683060 DOI: 10.1007/s00216-022-04489-3] [Reference Citation Analysis]
12 Schebb NH, Steinhilber D. What Mediates the Inflammation Resolution? Function (Oxf) 2023;4:zqac067. [PMID: 36628185 DOI: 10.1093/function/zqac067] [Reference Citation Analysis]
13 Hofling U, Tacconelli S, Contursi A, Bruno A, Mucci M, Ballerini P, Cohen S, Patrignani P. Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro. Front Pharmacol 2022;13:1070277. [PMID: 36588714 DOI: 10.3389/fphar.2022.1070277] [Reference Citation Analysis]
14 Daly K, O'Sullivan K, O'Sullivan TP. Major structure-activity relationships of resolvins, protectins, maresins and their analogues. Future Med Chem 2022;14:1943-60. [PMID: 36449363 DOI: 10.4155/fmc-2022-0206] [Reference Citation Analysis]
15 Wedel S, Hahnefeld L, Alnouri MW, Offermanns S, Hausch F, Geisslinger G, Sisignano M. The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury. Int J Mol Sci 2022;23. [PMID: 36430751 DOI: 10.3390/ijms232214274] [Reference Citation Analysis]
16 Benatzy Y, Palmer MA, Brüne B. Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1042420] [Reference Citation Analysis]
17 Osterath B. Entzündungsauflösende Mediatoren: Signal oder Rauschen? Nachr Chem 2022;70:58-60. [DOI: 10.1002/nadc.20224132822] [Reference Citation Analysis]
18 Dahlgren C, Lind S, Mårtensson J, Björkman L, Wu Y, Sundqvist M, Forsman H. G protein coupled pattern recognition receptors expressed in neutrophils : Recognition, activation/modulation, signaling and receptor regulated functions. Immunological Reviews 2022. [DOI: 10.1111/imr.13151] [Reference Citation Analysis]
19 Fu X, Yin HH, Wu MJ, He X, Jiang Q, Zhang LT, Liu JY. High Sensitivity and Wide Linearity LC-MS/MS Method for Oxylipin Quantification in Multiple Biological Samples. J Lipid Res 2022;63:100302. [PMID: 36265716 DOI: 10.1016/j.jlr.2022.100302] [Reference Citation Analysis]
20 Janciauskiene S, Tumpara S, Schebb NH, Buettner FFR, Mainka M, Sivaraman K, Immenschuh S, Grau V, Welte T, Olejnicka B. Indirect effect of alpha-1-antitrypsin on endotoxin-induced IL-1β secretion from human PBMCs. Front Pharmacol 2022;13:995869. [DOI: 10.3389/fphar.2022.995869] [Reference Citation Analysis]
21 Yamaguchi A, Botta E, Holinstat M. Eicosanoids in inflammation in the blood and the vessel. Front Pharmacol 2022;13:997403. [PMID: 36238558 DOI: 10.3389/fphar.2022.997403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Contursi A, Tacconelli S, Hofling U, Bruno A, Dovizio M, Ballerini P, Patrignani P. Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk. Biochem Pharmacol 2022;205:115252. [PMID: 36130648 DOI: 10.1016/j.bcp.2022.115252] [Reference Citation Analysis]
23 Rao Z, Caprioglio D, Gollowitzer A, Kretzer C, Imperio D, Collado JA, Waltl L, Lackner S, Appendino G, Muñoz E, Temml V, Werz O, Minassi A, Koeberle A. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages. Biochem Pharmacol 2022;203:115202. [PMID: 35932797 DOI: 10.1016/j.bcp.2022.115202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Radmark O. Formation of eicosanoids and other oxylipins in human macrophages. Biochem Pharmacol 2022;204:115210. [PMID: 35973581 DOI: 10.1016/j.bcp.2022.115210] [Reference Citation Analysis]
25 Liu J. Editorial: Eicosanoids and cytokines: Resolution of inflammation. Front Pharmacol 2022;13:978331. [DOI: 10.3389/fphar.2022.978331] [Reference Citation Analysis]
26 Pflieger FJ, Wolf J, Feldotto M, Nockher A, Wenderoth T, Hernandez J, Roth J, Ott D, Rummel C. Norepinephrine Inhibits Lipopolysaccharide-Stimulated TNF-α but Not Oxylipin Induction in n-3/n-6 PUFA-Enriched Cultures of Circumventricular Organs. Int J Mol Sci 2022;23:8745. [PMID: 35955879 DOI: 10.3390/ijms23158745] [Reference Citation Analysis]
27 Yamamoto S, Hashidate-yoshida T, Shimizu T, Shindou H. Profiling of fatty acid metabolism in the dorsal root ganglion after peripheral nerve injury. Front Pain Res 2022;3. [DOI: 10.3389/fpain.2022.948689] [Reference Citation Analysis]
28 Fodil M, Blanckaert V, Ulmann L, Mimouni V, Chénais B. Contribution of n-3 Long-Chain Polyunsaturated Fatty Acids to the Prevention of Breast Cancer Risk Factors. IJERPH 2022;19:7936. [DOI: 10.3390/ijerph19137936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Barnig C, Lutzweiler G, Giannini M, Lejay A, Charles AL, Meyer A, Geny B. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins. Antioxidants (Basel) 2022;11:1213. [PMID: 35740110 DOI: 10.3390/antiox11061213] [Reference Citation Analysis]
30 Shum M, London CM, Briottet M, Sy KA, Baillif V, Philippe R, Zare A, Ghorbani-dalini S, Remus N, Tarze A, Escabasse V, Epaud R, Dubourdeau M, Urbach V. CF Patients’ Airway Epithelium and Sex Contribute to Biosynthesis Defects of Pro-Resolving Lipids. Front Immunol 2022;13:915261. [DOI: 10.3389/fimmu.2022.915261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]